A1439

Pituitary adenylate cyclase activating polypeptide-38

• Sinónimos: PACAP-38
• Fórmula empírica (notación de Hill): C₂₀₃H₃₃₁N₆₃O₅₃S
• Número CAS: 137061-48-4
• Peso molecular: 4534.26
• UNSPSC Code: 41106305
• NACRES: NA.32
• MDL number: MFCD00081800
• Form: powder

Propiedades

• form: powder
• Quality Segment: 200
• composition: Peptide content, ~70%
• UniProt accession no.: P18509
• storage temp.: −20°C
• Gene Information: human ... ADCYAP1(116)

Descripción

General description

Pituitary adenylate cyclase activating polypeptide-38 (PACAP38) is mapped to human chromosome 18. 27-residue-amidated fragment (PACAP27) comprises another isoform. The PACAP38 is major isoform associated with mammals.

Application

Pituitary adenylate cyclase activating polypeptide-38 has been used to test its effect in stimulating the formation of cyclic AMP hypothalamus and cerebral cortex slices of chicken and to treat glioblastoma cells (U87MG) in cell migration assay to test its anti-invasive effects.

Biochem/physiol Actions

PACAP-38 is a neuropeptide that has substantial sequence homology to vasoactive intestinal peptide (VIP). It is reported to serve as a neuronal survival factor.

Pituitary adenylate cyclase activating polypeptide-38 (PACAP38) is a cardioprotectant and may help in treating radiation-induced heart disease (RIHD). It plays a protective role during oxidative stress in cardiomyocytes. PACAP38 has antioxidant, anti-apoptotic and anti-inflammatory property. It is implicated in the pathophysiology of migraine and cluster headache.

Other Notes

Lyophilized from 0.1% TFA in H2O

Información de seguridad

• Clase de almacenamiento: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)